Report ID: SQMIG35H2188
Report ID:
SQMIG35H2188 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
97 |
Figures:
70
In 2022, North America emerged as the dominant market player, commanding a substantial share of over 40.0%. This market leadership can be attributed to the region's well-established biopharmaceutical and Contract Research Organization (CRO) industry, which has been a hub of extensive research and development (R&D) activities.
The Asia Pacific region is expected to experience the most rapid CAGR from 2023 to 2030. This growth trajectory is attributed to the burgeoning life sciences industry and the increasing attraction of contract service providers to the region. The Asia Pacific region is characterized by rapid economic development and substantial investments in research and development activities, particularly in emerging economies such as China and India.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2188